MBX Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
MBX Biosciences has a total shareholder equity of $271.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $282.4M and $11.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$277.06m |
| Equity | US$271.37m |
| Total liabilities | US$11.03m |
| Total assets | US$282.40m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: MBX's short term assets ($281.2M) exceed its short term liabilities ($10.9M).
Long Term Liabilities: MBX's short term assets ($281.2M) exceed its long term liabilities ($112.0K).
Debt to Equity History and Analysis
Debt Level: MBX is debt free.
Reducing Debt: MBX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MBX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MBX has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 39.3% each year.